Evolent Health, Inc.
EVH
$2.99
-$0.07-2.29%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -26.56% | -16.65% | -6.71% | 10.24% | 30.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -26.56% | -16.65% | -6.71% | 10.24% | 30.09% |
| Cost of Revenue | -32.51% | -19.09% | -4.18% | 17.62% | 45.49% |
| Gross Profit | 8.86% | -3.80% | -17.79% | -18.25% | -20.22% |
| SG&A Expenses | 16.98% | 11.94% | -2.41% | -12.32% | -17.51% |
| Depreciation & Amortization | 19.72% | -33.85% | -30.30% | -26.14% | -21.59% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -25.69% | -16.69% | -5.35% | 11.04% | 31.41% |
| Operating Income | -118.58% | -13.08% | -72.26% | -40.59% | -37.07% |
| Income Before Tax | -748.14% | -46.54% | -39.50% | 16.40% | 68.86% |
| Income Tax Expenses | 91.08% | 102.88% | 94.49% | 97.54% | 98.42% |
| Earnings from Continuing Operations | -767.39% | -77.46% | -75.30% | 1.25% | 45.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -767.39% | -77.46% | -75.30% | 1.25% | 45.49% |
| EBIT | -118.58% | -13.08% | -72.26% | -40.59% | -37.07% |
| EBITDA | -7.29% | -34.17% | -48.68% | -34.55% | -29.42% |
| EPS Basic | -442.23% | -82.69% | -81.89% | -5.23% | 28.42% |
| Normalized Basic EPS | -8,053.95% | -986.24% | -467.11% | -2,073.68% | 101.81% |
| EPS Diluted | -442.23% | -82.69% | -81.89% | -5.23% | 28.42% |
| Normalized Diluted EPS | -8,053.95% | -986.24% | -467.11% | -2,073.68% | 101.81% |
| Average Basic Shares Outstanding | -0.40% | 0.66% | 1.41% | 1.91% | 3.10% |
| Average Diluted Shares Outstanding | -0.40% | 0.66% | 1.41% | 1.91% | 3.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.94% | 0.56% | 0.46% | 0.02% | -0.96% |